Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CNVCF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
proactiveinvestors.com
8 hours ago
proactiveinvestors.com
9 hours ago
proactiveinvestors.com
11 hours ago
proactiveinvestors.com
11 hours ago
proactiveinvestors.com
15 hours ago
proactiveinvestors.com
16 hours ago
Relative Strength
CNVCF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.16
vs -0.11
Q1.23
N/A
-0.04
vs -0.13
Q2.23
N/A
-0.16
vs -0.14
Q3.23
N/A
-0.10
vs -0.22
Q4.23
N/A
-0.39
vs -0.16
Q1.24
N/A
-0.70
vs -0.04
Q2.24
N/A
-0.04
vs -0.16
Q3.24
+100%
NA
vs -0.10
Q4.24
+108%
0.03
vs -0.39
Q1.25
+103%
0.02
vs -0.70
Sales Growth
YoY
Current
Estimates
Q4.22
+235%
2.4M vs 730K
Q1.23
+209%
2.2M vs 699K
Q2.23
+228%
2.8M vs 838K
Q3.23
+114%
3.2M vs 1.5M
Q4.23
+85%
4.5M vs 2.4M
Q1.24
+147%
5.3M vs 2.2M
Q2.24
+119%
6M vs 2.8M
Q3.24
+102%
6.5M vs 3.2M
Q4.24
+61%
7.3M vs 4.5M
Q1.25
+70%
9.1M vs 5.3M
Return on Equity
QoQ
Q1.23
+15%
0.15
vs 0.47
Q2.23
+46%
0.46
vs 0.15
Q3.23
+22%
0.22
vs 0.46
Q4.23
+49%
0.49
vs 0.22
Q1.24
+207%
2.07
vs 0.49
Q2.24
-10%
-0.10
vs 2.07
Q3.24
-65%
-0.65
vs -0.10
Q4.24
-222%
-2.22
vs -0.65
Institutionnal Ownership
Quote Panel
Key Metrics
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
OTC
Unprofitable
EPS improving
Unprofitable
EPS improving
Relative Strenght
Volume Buzz
100%
Earning Acce
Yes
Dist 52w H.
NaN%Forecast
1340%2025-Revenue
240%2025-EPS
-5030%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available